Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration-Reference-Cited by-同舟云学术

Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration

Published:2024-05 Issue: Volume:175 Page:105724
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Kountouras Jannis^ORCID,Boziki Marina,Kazakos Evangelos,Theotokis Paschalis,Kesidou Evangelia,Nella Maria,Bakirtzis Christos,Karafoulidou Eleni,Vardaka Elisabeth,Mouratidou Maria C.,Kyrailidi Foteini,Tzitiridou-Chatzopoulou Maria,Orovou Eirini,Giartza-Taxidou Evaggelia,Deretzi Georgia,Grigoriadis Nikolaos,Doulberis Michael

Publisher

Elsevier BV

Reference299 articles.

1. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD) in a developing Country: a cross-sectional study;Abo-Amer;Diabetes Metab. Syndr. Obes.,2020

2. Interactions between amyloid-beta proteins and human brain pericytes: implications for the Pathobiology of Alzheimer's disease;Alcendor;J. Clin. Med.,2020

3. Mast cells: an expanding pathophysiological role from allergy to other disorders;Anand;Naunyn-Schmiedeberg’s Arch. Pharmacol.,2012

4. Alzheimer's disease severity is associated with an Imbalance in serum levels of enzymes regulating Plasmin synthesis;Angelucci;Pharmaceuticals,2022

5. Helicobacter pylori infection and risk of multiple sclerosis: an updated meta-analysis;Arjmandi;Helicobacter,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH;Alimentary Pharmacology & Therapeutics;2024-07-30

2. Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease;Alimentary Pharmacology & Therapeutics;2024-07-03

3. The 1st EoETALY consensus on the diagnosis and management of eosinophilic esophagitis and the missing link: Helicobacter pylori infection;Digestive and Liver Disease;2024-07